Filing Details
- Accession Number:
- 0001171843-15-000193
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2015-01-12 16:15:01
- Reporting Period:
- 2015-01-02
- Filing Date:
- 2015-01-12
- Accepted Time:
- 2015-01-12 16:15:01
- Original Submission Date:
- 2015-01-06
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
3116 | Akorn Inc | AKRX | Pharmaceutical Preparations (2834) | 720717400 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1277838 | M Ronald Johnson | 1925 West Field Court Suite 300 Lake Forest IL 60045 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2015-01-02 | 14,300 | $36.12 | 134,310 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2014.
- Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $35.49 to $36.88 per share. The reporting person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at separate prices within the foregoing range.